KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Stryker (SYK) Research & Development (2016 - 2025)

Stryker (SYK) has disclosed Research & Development for 17 consecutive years, with $401.0 million as the latest value for Q4 2025.

  • Quarterly Research & Development rose 12.01% to $401.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 billion through Dec 2025, up 10.71% year-over-year, with the annual reading at $1.6 billion for FY2025, 10.71% up from the prior year.
  • Research & Development for Q4 2025 was $401.0 million at Stryker, down from $410.0 million in the prior quarter.
  • The five-year high for Research & Development was $413.0 million in Q1 2022, with the low at $288.0 million in Q1 2021.
  • Average Research & Development over 5 years is $358.3 million, with a median of $355.5 million recorded in 2023.
  • The sharpest move saw Research & Development soared 43.4% in 2022, then decreased 17.92% in 2023.
  • Over 5 years, Research & Development stood at $331.0 million in 2021, then decreased by 1.51% to $326.0 million in 2022, then increased by 7.36% to $350.0 million in 2023, then grew by 2.29% to $358.0 million in 2024, then rose by 12.01% to $401.0 million in 2025.
  • According to Business Quant data, Research & Development over the past three periods came in at $401.0 million, $410.0 million, and $407.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.